Immaterial Corrections	12 Months Ended
Dec. 31, 2012
Immaterial Corrections	NOTE 22 Immaterial Corrections Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2011, we identified the need for immaterial corrections to the Consolidated Statements of Cash Flows for the years ended December 31, 2011 and December 31, 2010. The first correction relates to the classification of global cash pooling activity with Exelis and Xylem within the financing activities of continuing operations. This correction resulted in a decrease to the line “Distributions of Exelis and Xylem, net” in financing cash flows of continuing operations of $279.0 and $199.0 for the years ended December 31, 2011 and December 31, 2010, respectively. The second correction resulted in adjustments to discontinued operations operating and financing activities of $62.0 and ($209.3), respectively, for the year ended December 31, 2011 and $233.0 and ($237.0), respectively, for the year ended December 31, 2010. Lastly, we revised the presentation of the reconciliation of cash and cash equivalents to include the cash and cash equivalents of discontinued operations within the Statements of Cash Flows, including the $400.0 cash distribution to Exelis and Xylem at the Distribution Date. The adjustments had no effect on the cash and cash equivalents of continuing operations, Consolidated Balance Sheets, Consolidated Income Statements or Consolidated Statements of Comprehensive Income. Additionally, during the year ended December 31, 2012, we decreased the Distribution of Exelis and Xylem within shareholder’s equity by $0.3 as a result of immaterial corrections primarily related to various assets and liabilities associated with those entities.

NOTE 22

Immaterial Corrections

Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2011, we identified the need for immaterial corrections to the Consolidated Statements of Cash Flows for the years ended December 31, 2011 and December 31, 2010. The first correction relates to the classification of global cash pooling activity with Exelis and Xylem within the financing activities of continuing operations. This correction resulted in a decrease to the line “Distributions of Exelis and Xylem, net” in financing cash flows of continuing operations of $279.0 and $199.0 for the years ended December 31, 2011 and December 31, 2010, respectively. The second correction resulted in adjustments to discontinued operations operating and financing activities of $62.0 and ($209.3), respectively, for the year ended December 31, 2011 and $233.0 and ($237.0), respectively, for the year ended December 31, 2010. Lastly, we revised the presentation of the reconciliation of cash and cash equivalents to include the cash and cash equivalents of discontinued operations within the Statements of Cash Flows, including the $400.0 cash distribution to Exelis and Xylem at the Distribution Date.

The adjustments had no effect on the cash and cash equivalents of continuing operations, Consolidated Balance Sheets, Consolidated Income Statements or Consolidated Statements of Comprehensive Income.

Additionally, during the year ended December 31, 2012, we decreased the Distribution of Exelis and Xylem within shareholder’s equity by $0.3 as a result of immaterial corrections primarily related to various assets and liabilities associated with those entities.